Near Infrared Imaging Quadrant Report

Request Free Sample Report
Near Infrared Imaging Market (Global) Company Evaluation Quadrant
Published on
Feb'2019
Pages
56
Code
360-MD 4138
Email
Share
Request Free Sample Report

Near-Infrared Imaging uses near-infrared light between 650 and 950 nm to non-invasively probe the concentration and oxygenation of hemoglobin in the brain, muscle, and other tissues. It is used to detect changes induced by brain activity, injury, or disease.

The near-infrared imaging market is expected to reach USD 822 million by 2023. Factors contributing to the growth of the near-infrared imaging market include an increasing number of global surgical procedures owing to the rising prevalence of target diseases and the growing adoption of NIR imaging over conventional visualization methods. The growth potential in emerging economies is predicted to present market players with a wide range of opportunities.

ADVANTAGES OF NIR IMAGING OVER CONVENTIONAL VISUALIZATION METHODS TO DRIVE THE GROWTH OF THE NEAR INFRARED IMAGING MARKET

Major industry end-users adopting the near-infrared imaging technology include pharmaceutical & biotechnology companies, hospitals & clinics, and research laboratories. Some significant players that are profiled in the report include PerkinElmer (US), LI-COR, Inc. (US), Fluoptics (France), Hamamatsu Photonics K.K  (Japan), and Quest Medical Imaging B.V.  (Netherlands). 

The report evaluates key players in the Near-Infrared market based on business strategy excellence and strength of product portfolio, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called as ‘Company Evaluation Quadrant,’ and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.

The report includes market-specific company profiles of 13 key players and assesses the recent developments that shape the competitive landscape of this market.


List of companies evaluated and profiled in the report:

  • CARL ZEISS MEDITECH AG
  • FLUOPTICS
  • HAMAMATSU PHOTONICS K.K
  • KARL STORZ SE & CO.KG
  • LEICA MICROSYSTEMS
  • LI-COR, INC.
  • MEDTRONIC
  • MIZUHO MEDICAL CO., LTD.
  • OLYMPUS CORPORATION
  • PERKINELMER, INC.
  • QUEST MEDICAL IMAGING B.V.
  • SHIMADZU CORPORATION
  • STRYKER CORPORATION

Table of Contents

1 Introduction
   1.1 Market Definition

2 Market Overview
   2.1 Introduction
   2.2 Market Dynamics
         Figure 1 Near-Infrared Imaging Market: Drivers, Restraints, Opportunities, and Challenges
         2.2.1 Drivers
                   2.2.1.1 Increasing Number of Global Surgical Procedures Owing to the Rising Prevalence of Target Diseases
                   2.2.1.2 Advantages of NIR Imaging Over Conventional Visualization Methods
                                Table 1 Advantages of NIR Imaging Over Conventional Visualization Methods
         2.2.2 Restraints
                   2.2.2.1 Lengthy Approval Process Limiting the Availability of Targeted Fluorophores
         2.2.3 Opportunities
                   2.2.3.1 Growth Potential in Emerging Economies
         2.2.4 Challenges
                   2.2.4.1 Scarcity of Trained Professionals

3 Company Evaluation Quadrant
   3.1 Visionary Leaders
   3.2 Dynamic Differentiators
   3.3 Innovators
   3.4 Emerging Companies
          Figure 2 Near Infrared Imaging Market (Global) Company Evaluation Quadrant

4 Competitive Landscape
   4.1 Overview
          Figure 3 Organic and Inorganic Strategies Adopted By Key Players in the Near-Infrared Imaging Market
   4.2 Market Share Analysis
          Figure 4 Near-Infrared Fluorescence Imaging Systems Market Share Analysis, By Key Player, 2017
   4.3 Competitive Situations and Trends
         4.3.1 Changing Competitive Landscape as Large Corporations Enter the NIR Imaging Market
                   Figure 5 Strategies Adopted By Market Players (2015–2018)
         4.3.2 Product Launches and Approvals
                   Table 2 Product Launches and Approvals
         4.3.3 Expansions
                   Table 3 Expansions
         4.3.4 Agreements, Collaborations, and Partnerships
                   Table 4 Agreements, Collaborations, and Partnerships
         4.3.5 Acquisitions
                   Table 5 Acquisitions

5 Company Profiles
   5.1 Stryker
         5.1.1 Business Overview*
                   Figure 6 Company Snapshot: Stryker Corporation (2017)
         5.1.2 Products Offered*
         5.1.3 Recent Developments*
         5.1.4 SWOT Analysis*
         5.1.5 MnM View*
         (*Above sections are present for all of below companies)
   5.2 KARL STORZ SE & Co. KG

   5.3 Carl Zeiss Meditech AG
          Figure 7 Company Snapshot: Carl Zeiss Meditech AG (2018)
   5.4 Leica Microsystems (A Subsidiary of Danaher Corporation)
          Figure 8 Danaher Corporation: Company Snapshot (2017)
   5.5 Olympus Corporation
          Figure 9 Olympus Corporation (2017): Company Snapshot
   5.6 PerkinElmer, Inc.
          Figure 10 Company Snapshot: Perkinelmer, Inc. (2017)
   5.7 LI-COR, Inc.
   5.8 Hamamatsu Photonics K.K.
          Figure 11 Company Snapshot: Hamamatsu Photonics K.K. (2017)
   5.9 Quest Medical Imaging B.V.
   5.10 Mizuho Medical Co., Ltd.
   5.11 Fluoptics
   5.12 Shimadzu Corporation
            Figure 12 Shimadzu Corporation: Company Snapshot (2017)
   5.13 Medtronic

6 Appendix
   6.1 Methodology

This report identifies and benchmarks the key market players in the Near Infrared Imaging Market including Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditech AG (Germany), Leica Microsystems (Germany), and Shimadzu Corporation (Japan), and evaluates them based on business strategy excellence and strength of product portfolio within the Near Infrared Imaging ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called as ‘Company Evaluation Quadrant,’ and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies. 

SAMPLES:





1450 USD
Licensing Options
Personalize Your Research Requirement
  • Updated version of this Quadrant
  • Different Company Evaluation Quadrant
  • 'Startup Only' Company Evaluation Quadrant
  • Region or Country specific evaluation
  • Application or Industry specific evaluation
  • ..Read More
Analyst Briefing & Inquiry
  • Submit a Briefing Request
  • Question about our published research
  • Request for evaluation of your organization for specific market
  • Request for re-evaluation of Company Evaluation Quadrant
  • ..Read More